These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 11400962)
1. The breast cancer patient with multiple sentinel nodes: when to stop? McCarter MD; Yeung H; Fey J; Borgen PI; Cody HS J Am Coll Surg; 2001 Jun; 192(6):692-7. PubMed ID: 11400962 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer. Choi SH; Barsky SH; Chang HR Breast J; 2003; 9(3):153-62. PubMed ID: 12752622 [TBL] [Abstract][Full Text] [Related]
3. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Cox CE; Pendas S; Cox JM; Joseph E; Shons AR; Yeatman T; Ku NN; Lyman GH; Berman C; Haddad F; Reintgen DS Ann Surg; 1998 May; 227(5):645-51; discussion 651-3. PubMed ID: 9605656 [TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate. Wong SL; Edwards MJ; Chao C; Tuttle TM; Noyes RD; Carlson DJ; Cerrito PB; McMasters KM J Am Coll Surg; 2001 Jun; 192(6):684-9; discussion 689-91. PubMed ID: 11400961 [TBL] [Abstract][Full Text] [Related]
5. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase. Goyal A; Newcombe RG; Chhabra A; Mansel RE; Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308 [TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node pressure in breast cancer. Nathanson SD; Mahan M Ann Surg Oncol; 2011 Dec; 18(13):3791-6. PubMed ID: 21626079 [TBL] [Abstract][Full Text] [Related]
7. High isotope counts and sentinel node positivity in patients with melanoma. Jacobs IA; Chang CK; DasGupta TK; Salti G Arch Surg; 2003 Jan; 138(1):63-6; discussion 67. PubMed ID: 12511153 [TBL] [Abstract][Full Text] [Related]
8. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer. Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937 [TBL] [Abstract][Full Text] [Related]
9. Sentinel node biopsy in ductal carcinoma in situ patients. Pendas S; Dauway E; Giuliano R; Ku N; Cox CE; Reintgen DS Ann Surg Oncol; 2000; 7(1):15-20. PubMed ID: 10674443 [TBL] [Abstract][Full Text] [Related]
10. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy. Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081 [TBL] [Abstract][Full Text] [Related]
11. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes. Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139 [TBL] [Abstract][Full Text] [Related]
12. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. For the University of Louisville Breast Cancer Study Group. Martin RC; Edwards MJ; Wong SL; Tuttle TM; Carlson DJ; Brown CM; Noyes RD; Glaser RL; Vennekotter DJ; Turk PS; Tate PS; Sardi A; Cerrito PB; McMasters KM Surgery; 2000 Aug; 128(2):139-44. PubMed ID: 10922983 [TBL] [Abstract][Full Text] [Related]
13. Is the "10% rule" equally valid for all subsets of sentinel-node-positive breast cancer patients? Chung A; Yu J; Stempel M; Patil S; Cody H; Montgomery L Ann Surg Oncol; 2008 Oct; 15(10):2728-33. PubMed ID: 18688679 [TBL] [Abstract][Full Text] [Related]
14. Intraoperative subareolar injection of 99mTc-labeled sulfur colloid results in consistent sentinel lymph node identification. Zogakis TG; Wetherille RE; Christensen RD; Ose KJ; Friedman JD; Colbert M; Svendsen CA; Sanan OK; Tuttle TM Ann Surg Oncol; 2005 Feb; 12(2):167-72. PubMed ID: 15827798 [TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer. Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy. Albo D; Ames FC; Hunt KK; Ross MI; Singletary SE; Kuerer HM Breast Cancer Res Treat; 2003 Jan; 77(1):9-14. PubMed ID: 12602900 [TBL] [Abstract][Full Text] [Related]
17. Comparison of [(99m)Tc]tilmanocept and filtered [(99m)Tc]sulfur colloid for identification of SLNs in breast cancer patients. Baker JL; Pu M; Tokin CA; Hoh CK; Vera DR; Messer K; Wallace AM Ann Surg Oncol; 2015 Jan; 22(1):40-5. PubMed ID: 25069859 [TBL] [Abstract][Full Text] [Related]
18. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma. Boolbol SK; Fey JV; Borgen PI; Heerdt AS; Montgomery LL; Paglia M; Petrek JA; Cody HS; Van Zee KJ Ann Surg Oncol; 2001; 8(1):20-4. PubMed ID: 11206219 [TBL] [Abstract][Full Text] [Related]
19. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. Derossis AM; Fey J; Yeung H; Yeh SD; Heerdt AS; Petrek J; VanZee KJ; Montgomery LL; Borgen PI; Cody HS J Am Coll Surg; 2001 Nov; 193(5):473-8. PubMed ID: 11708502 [TBL] [Abstract][Full Text] [Related]